ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,158,046 | -12.0% | 669,051 | -0.4% | 0.02% | -10.0% |
| Q2 2023 | $20,642,495 | +14.5% | 671,519 | +34.2% | 0.02% | +11.1% |
| Q1 2023 | $18,034,132 | +11.2% | 500,531 | +21.9% | 0.02% | +5.9% |
| Q4 2022 | $16,223,236 | -2.6% | 410,507 | -0.9% | 0.02% | -10.5% |
| Q3 2022 | $16,650,000 | -0.7% | 414,398 | +4.0% | 0.02% | +11.8% |
| Q2 2022 | $16,759,000 | +16.3% | 398,610 | +7.7% | 0.02% | +41.7% |
| Q1 2022 | $14,416,000 | +36.6% | 369,981 | +39.7% | 0.01% | +100.0% |
| Q4 2021 | $10,550,000 | +88.0% | 264,792 | +70.5% | 0.01% | +100.0% |
| Q3 2021 | $5,612,000 | -9.3% | 155,312 | +2.9% | 0.00% | 0.0% |
| Q2 2021 | $6,185,000 | +22.3% | 150,884 | +30.1% | 0.00% | 0.0% |
| Q1 2021 | $5,056,000 | +15.3% | 115,947 | +32.4% | 0.00% | +50.0% |
| Q4 2020 | $4,384,000 | – | 87,579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |